WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Apr 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-04-27

Reporting Person: Favorite Annette F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-27	Common Stock	M	4728.00	$55.09	Acquired	12936.9617	Direct
2020-04-27	Common Stock	M	9464.00	$55.09	Acquired	22400.9617	Direct
2020-04-27	Common Stock	S	2600.00	$195.4855	Disposed	19800.9617	Direct
2020-04-27	Common Stock	S	5431.00	$196.6035	Disposed	14369.9617	Direct
2020-04-27	Common Stock	S	4261.00	$197.483	Disposed	10108.9617	Direct
2020-04-27	Common Stock	S	1900.00	$198.3841	Disposed	8208.9617	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-27	Stock Option (Right to Buy)	$55.09	M	4728.00	Disposed	2025-10-05	Common Stock (4728.00)	Direct
2020-04-27	Stock Option (Right to Buy)	$55.09	M	9464.00	Disposed	2025-10-05	Common Stock (9464.00)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $196.07 USD to $197.06 USD; the price reported above reflects the weighted average sale price.

F2: This transaction was executed in multiple trades at prices ranging from $197.08 USD to $198.0067 USD; the price reported above reflects the weighted average sale price.

F3: This transaction was executed in multiple trades at prices ranging from $198.11 USD to $198.56 USD; the price reported above reflects the weighted average sale price.